Company Profile
Biotricity Stock Price, News & Analysis
- Ticker:
- BTCY
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.11 USD (+3.46%)
Close
Last updated: August 6, 2026
—
Market cap
Why the stock is moving
As of Aug 6, 2026, BTCY closed up 3.46% at $0.1100. No new same-company headline was identified in the current news window.
Company overview
Business overview
Biotricity is a medical technology company focused on remote cardiac monitoring and diagnostics. Its business is centered on connected devices and recurring monitoring workflows.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Biotricity sits in digital health and medtech.
Business Model Characteristics
The company depends on device adoption, subscription revenue, and the expansion of its cardiac-monitoring platform.
Position Within the Biotechnology Landscape
Biotricity is outside biotech and belongs to the connected-cardiac-device layer.
Future catalysts
Biotricity’s catalysts are remote-cardiac-monitoring adoption, recurring diagnostics, and payer support. The company improves when its device and software base becomes more embedded in clinical workflows.
Recent news
- 01
- 02
- 03
Biotricity Submitted 510(k) U.S. FDA Filing for Biotres
Source: Biotricity
- 04
- 05
Biotricity Prepares 510(k) FDA Filing for Biotres
Source: Biotricity
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Biotricity (BTCY)?
Biotricity (BTCY) most recently closed at 0.11 USD, a +3.46% move versus the previous session.
What does Biotricity do?
Biotricity is a medical technology company focused on remote cardiac monitoring and diagnostics. Its business is centered on connected devices and recurring monitoring workflows.
On which exchange is BTCY stock listed?
Biotricity (BTCY) is associated with NASDAQ, United States, Biopharma.
What is Biotricity?
Biotricity’s catalysts are remote-cardiac-monitoring adoption, recurring diagnostics, and payer support.
Which conditions is Biotricity targeting with Biotricity?
Biotricity’s catalysts are remote-cardiac-monitoring adoption, recurring diagnostics, and payer support.
How does Biotricity describe recent progress with Biotricity?
Biotricity’s catalysts are remote-cardiac-monitoring adoption, recurring diagnostics, and payer support.
What future catalysts are investors watching for Biotricity?
Biotricity’s catalysts are remote-cardiac-monitoring adoption, recurring diagnostics, and payer support. The company improves when its device and software base becomes more embedded in clinical workflows.